Used primarily in pharmaceutical research, (2,3-Dichlorobenzyl)methylamine serves as a key intermediate in the synthesis of various bioactive compounds. It is particularly valuable in the development of potential therapeutic agents targeting neurological disorders, such as depression and anxiety, due to its ability to interact with neurotransmitter systems. Additionally, it finds application in the creation of ligands for receptor studies, aiding in the understanding of biochemical pathways and drug mechanisms. Its role in organic synthesis also extends to the production of specialized chemicals for experimental and industrial purposes.